ArticlePathogens (Basel, Switzerland)2026
Two Multidrug-Resistant
Jingrui Zhang, Xiao Liu, Li Liu, Yeshun Fan, Zhiwen Sun, Mengjie Li, Yanwen Xiong, Zengbin Liu, Yanfang Li, Lili Yu and 3 more
Abstract readCase Reports
In one paragraphArticle in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Jingrui ZhangDepartment of Clinical Laboratory, The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China.ORCID 0009-0007-3316-0499 Xiao LiuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.ORCID 0009-0008-6204-1314 Li LiuDepartment of Clinical Laboratory, The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China.
Yeshun FanNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Zhiwen SunNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Mengjie LiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yanwen XiongNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.ORCID 0000-0001-6154-6902 Zengbin LiuDepartment of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang 050061, China.ORCID 0009-0008-0327-6033 Yanfang LiDepartment of Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang 050061, China.ORCID 0000-0001-9830-6574 Lili YuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050061, China.
Hongru FengDepartment of The North Campus, The Second Hospital of Hebei Medical University, Shijiazhuang 050061, China.
Duochun WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.ORCID 0000-0003-2372-1532 Jingxiao ZhangDepartment of Gynecology, The Fourth Hospital of Shijiazhuang, Shijiazhuang 050011, China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Patients undergoing cervical conization for cervical intraepithelial neoplasia grade II (CIN II) may develop postoperative bloodstream infections (BSIs), and multidrug-resistant (MDR)
Indexed as
Drug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsUterine Cervical DysplasiaAdultAnti-Bacterial Agentsbeta-LactamasesBlood CultureFemaleGenome, BacterialHumansMicrobial Sensitivity TestsPhenotypeWhole Genome SequencingAnti-Bacterial Agentsbeta-LactamasesblaNDM-5blood culturescarbapenem resistancecomparative genomicsmultidrug-resistant Escherichia coli
Identifiers
PMID42198603
PMCPMC13209812
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390